• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移术前化疗后的完全病理缓解:神话还是现实?

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

作者信息

Adam René, Wicherts Dennis A, de Haas Robbert J, Aloia Thomas, Lévi Francis, Paule Bernard, Guettier Catherine, Kunstlinger Francis, Delvart Valérie, Azoulay Daniel, Castaing Denis

机构信息

AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 12 Avenue Paul Vaillant Couturier, F-94804 Villejuif, France.

出版信息

J Clin Oncol. 2008 Apr 1;26(10):1635-41. doi: 10.1200/JCO.2007.13.7471.

DOI:10.1200/JCO.2007.13.7471
PMID:18375892
Abstract

PURPOSE

Complete clinical response (CCR) of colorectal liver metastases (CLM) following chemotherapy is of limited predictive value for complete pathologic response (CPR) and cure of the disease. The objective of this study was to determine predictive factors of CPR as well as its impact on survival.

PATIENTS AND METHODS

From January 1985 to July 2006, 767 consecutive patients with CLM underwent liver resection after systemic chemotherapy. Patients with CPR were compared with patients without CPR.

RESULTS

Twenty-nine of 767 (4%) patients had CPR, and none of these 29 patients had CCR. Patients with CPR (mean age, 54 years) had a mean number of 3.3 metastases at diagnosis (mean size, 29.3 mm). Objective response and stable disease were observed in 79% and 21% of cases, respectively. Postoperative mortality rate was 0%. After a median follow-up of 52.2 months (range, 1.1 to 193.0 months), overall 5-year survival was 76% for patients with CPR compared with 45% for patients without CPR (P = .004). Independent predictive factors for CPR were: age <or= 60 years, size of metastases <or= 3 cm at diagnosis, carcinoembryonic antigen (CEA) level at diagnosis <or= 30 ng/mL, and objective response following chemotherapy. The probability of CPR ranged from 0.2% when all factors were absent to 30.9% when all were present.

CONCLUSION

CPR was observed in 4% of patients with CLM treated with preoperative chemotherapy. However, CPR may occur in almost one-third of objective responders age <or= 60 years with metastases <or= 3 cm and low CEA values. CPR is associated with uncommon high survival rates.

摘要

目的

化疗后结直肠癌肝转移(CLM)的完全临床缓解(CCR)对疾病的完全病理缓解(CPR)及治愈的预测价值有限。本研究的目的是确定CPR的预测因素及其对生存的影响。

患者与方法

1985年1月至2006年7月,767例连续性CLM患者在全身化疗后接受肝切除术。将有CPR的患者与无CPR的患者进行比较。

结果

767例患者中有29例(4%)出现CPR,这29例患者均无CCR。有CPR的患者(平均年龄54岁)诊断时转移灶平均数量为3.3个(平均大小29.3mm)。分别有79%和21%的病例观察到客观缓解和疾病稳定。术后死亡率为0%。中位随访52.2个月(范围1.1至193.0个月)后,有CPR的患者5年总生存率为76%,无CPR的患者为45%(P = 0.004)。CPR的独立预测因素为:年龄≤60岁、诊断时转移灶大小≤3cm、诊断时癌胚抗原(CEA)水平≤30ng/mL以及化疗后的客观缓解。当所有因素均不存在时,CPR的概率为0.2%;当所有因素均存在时,CPR的概率为30.9%。

结论

术前化疗的CLM患者中有4%观察到CPR。然而,年龄≤60岁、转移灶≤3cm且CEA值低的客观缓解者中近三分之一可能出现CPR。CPR与罕见的高生存率相关。

相似文献

1
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?结直肠癌肝转移术前化疗后的完全病理缓解:神话还是现实?
J Clin Oncol. 2008 Apr 1;26(10):1635-41. doi: 10.1200/JCO.2007.13.7471.
2
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.新辅助化疗的反应不能预测同时性结直肠肝转移患者的总生存期。
Ann Surg Oncol. 2009 Jul;16(7):1844-51. doi: 10.1245/s10434-009-0348-1. Epub 2009 Feb 18.
3
Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?结直肠癌肝转移的肝冷冻疗法及联合或不联合切除术的区域化疗:多少转移灶算多?
Cancer. 2003 Jul 15;98(2):320-30. doi: 10.1002/cncr.11498.
4
Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.对于结直肠癌肝转移患者,术前化疗无反应并不排除肝切除术后的长期生存。
Surgery. 2009 Jul;146(1):52-9. doi: 10.1016/j.surg.2009.02.004. Epub 2009 Apr 21.
5
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.氟尿嘧啶联合奥沙利铂术前化疗后结直肠癌肝转移患者的肝脏组织学及手术结果
J Clin Oncol. 2006 Nov 1;24(31):4983-90. doi: 10.1200/JCO.2006.05.8156.
6
[Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].220例结直肠癌伴同时性肝转移患者的预后分析
Ai Zheng. 2006 Sep;25(9):1153-7.
7
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?初始不可切除的结直肠癌肝转移患者:有治愈的可能吗?
J Clin Oncol. 2009 Apr 10;27(11):1829-35. doi: 10.1200/JCO.2008.19.9273. Epub 2009 Mar 9.
8
Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.接受化疗的肝转移局限型乳腺癌患者的临床病程
Cancer J. 2008 Jan-Feb;14(1):62-8. doi: 10.1097/PPO.0b013e3181629a7b.
9
Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.围手术期癌胚抗原检测对预测结直肠癌肝转移切除术后的可治愈性:一项前瞻性研究。
Arch Surg. 2008 Dec;143(12):1150-8; discussion 1158-9. doi: 10.1001/archsurg.143.12.1150.
10
Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.长期新辅助化疗后进行肝大部切除时采用门静脉三联阻断(TC)还是肝血管阻断(VE)?一项对60例患者的病例匹配研究。
Surgery. 2006 Sep;140(3):396-403. doi: 10.1016/j.surg.2006.03.023. Epub 2006 Jul 27.

引用本文的文献

1
The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery.结直肠癌肝转移灶消失的挑战:权衡肿瘤生物学与肝脏手术临床后果之间的考量
Clin Exp Metastasis. 2025 Jul 12;42(4):39. doi: 10.1007/s10585-025-10357-y.
2
A Systematic Review of Disappearing Colorectal Liver Metastases: Resection or No Resection?结直肠癌肝转移灶消失:切除还是不切除?一项系统综述
J Clin Med. 2025 Feb 10;14(4):1147. doi: 10.3390/jcm14041147.
3
Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases.
基于影像组学的机器学习方法预测结直肠癌肝转移患者的化疗反应
J Anus Rectum Colon. 2025 Jan 25;9(1):117-126. doi: 10.23922/jarc.2024-077. eCollection 2025.
4
Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.不可切除肝细胞癌患者接受转化手术时病理反应的预后价值
Liver Cancer. 2024 Jan 27;13(5):498-508. doi: 10.1159/000536376. eCollection 2024 Oct.
5
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma.局部晚期肝内胆管癌新辅助化疗后的病理完全缓解
Surg Case Rep. 2024 Feb 9;10(1):35. doi: 10.1186/s40792-024-01832-x.
6
Recurrent Colorectal Liver Metastases: Upfront Local Treatment versus Neoadjuvant Systemic Therapy Followed by Local Treatment (COLLISION RELAPSE): Study Protocol of a Phase III Prospective Randomized Controlled Trial.复发性结直肠癌肝转移: upfront局部治疗与新辅助全身治疗后局部治疗(COLLISION RELAPSE):一项III期前瞻性随机对照试验的研究方案
Cardiovasc Intervent Radiol. 2024 Feb;47(2):253-262. doi: 10.1007/s00270-023-03602-y. Epub 2023 Nov 9.
7
Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?消失的结直肠癌肝转移灶:我们真的需要捉鬼敢死队吗?
Healthcare (Basel). 2022 Sep 28;10(10):1898. doi: 10.3390/healthcare10101898.
8
The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator.肝脏转移灶的病理完全缓解率是一种有价值的预后指标。
Pathol Oncol Res. 2022 Sep 6;28:1610663. doi: 10.3389/pore.2022.1610663. eCollection 2022.
9
Complete pathological response of post neoadjuvant chemotherapy in colorectal cancer with liver metastasis: a case report.结直肠癌肝转移新辅助化疗后的完全病理缓解:一例报告
J Surg Case Rep. 2022 Feb 19;2022(2):rjac041. doi: 10.1093/jscr/rjac041. eCollection 2022 Feb.
10
Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases.钇-90 选择性内照射治疗在结直肠癌肝转移手术管理中作用的叙述性综述
J Gastrointest Oncol. 2021 Oct;12(5):2438-2446. doi: 10.21037/jgo-21-96.